JP2001526641A5 - - Google Patents

Download PDF

Info

Publication number
JP2001526641A5
JP2001526641A5 JP1998544102A JP54410298A JP2001526641A5 JP 2001526641 A5 JP2001526641 A5 JP 2001526641A5 JP 1998544102 A JP1998544102 A JP 1998544102A JP 54410298 A JP54410298 A JP 54410298A JP 2001526641 A5 JP2001526641 A5 JP 2001526641A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998544102A
Other languages
English (en)
Other versions
JP2001526641A (ja
JP4550171B2 (ja
Filing date
Publication date
Priority claimed from US09/028,083 external-priority patent/US6696545B1/en
Application filed filed Critical
Priority claimed from PCT/US1998/007231 external-priority patent/WO1998046633A1/en
Publication of JP2001526641A publication Critical patent/JP2001526641A/ja
Publication of JP2001526641A5 publication Critical patent/JP2001526641A5/ja
Application granted granted Critical
Publication of JP4550171B2 publication Critical patent/JP4550171B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

Figure 2001526641
Figure 2001526641
Figure 2001526641
Figure 2001526641
Figure 2001526641
Figure 2001526641
Figure 2001526641
JP54410298A 1997-04-11 1998-04-10 免疫系活性を調節する及び炎症を阻害するための細胞調節親油性ペプチド Expired - Fee Related JP4550171B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US83891697A 1997-04-11 1997-04-11
US08/838,916 1997-04-11
US09/028,083 1998-02-23
US09/028,083 US6696545B1 (en) 1997-04-11 1998-02-23 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
PCT/US1998/007231 WO1998046633A1 (en) 1997-04-11 1998-04-10 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation

Publications (3)

Publication Number Publication Date
JP2001526641A JP2001526641A (ja) 2001-12-18
JP2001526641A5 true JP2001526641A5 (ja) 2006-01-05
JP4550171B2 JP4550171B2 (ja) 2010-09-22

Family

ID=26703275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54410298A Expired - Fee Related JP4550171B2 (ja) 1997-04-11 1998-04-10 免疫系活性を調節する及び炎症を阻害するための細胞調節親油性ペプチド

Country Status (14)

Country Link
US (1) US7267822B2 (ja)
EP (1) EP0973799B1 (ja)
JP (1) JP4550171B2 (ja)
CN (1) CN1216900C (ja)
AT (1) ATE352556T1 (ja)
AU (2) AU761717B2 (ja)
BR (1) BR9808529B1 (ja)
CA (1) CA2286478A1 (ja)
IL (1) IL132310A0 (ja)
NO (1) NO994898L (ja)
NZ (1) NZ500287A (ja)
PL (1) PL336302A1 (ja)
TR (1) TR199902786T2 (ja)
WO (1) WO1998046633A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773240B1 (fr) 1997-12-30 2002-11-29 Synt Em Procede pour prevoir, identifier et decrire des molecules susceptibles de presenter un comportement recherche, notamment dans le domaine de la pharmacie et molecules obtenues par ce procede
MXPA01010541A (es) * 1999-04-21 2003-08-19 Univ Georgia Res Found Cisteina proteasa e hinibidores para la prevencion y el tratamiento de la neurocisticercosis.
US7094413B2 (en) 2002-01-24 2006-08-22 Sangstat Medical Corporation Combined therapy for treatment of HIV infection
KR20040094745A (ko) * 2002-02-26 2004-11-10 상스타트 메디칼 코포레이션 세포제거 요법에 의해 유도된 위장 독성을 치료하는 방법및 조성물
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
JP2006516546A (ja) * 2002-11-15 2006-07-06 サングスタット メディカル コーポレイション 間質性膀胱炎の治療用細胞調節性ペプチド
WO2005001075A1 (en) * 2003-05-15 2005-01-06 Sangstat Medical Corporation Rdp58 compositions and methods for modulating the activity of osteoclasts and osteoblasts
WO2005009457A1 (en) * 2003-05-15 2005-02-03 Sangstat Medical Corporation Rdp58 compositions and methods for inhibiting vascularization of cell populations
US7498309B2 (en) 2003-11-29 2009-03-03 Sangstat Medical Corporation Pharmaceutical compositions for bioactive peptide agents
CN104231054A (zh) * 2014-09-01 2014-12-24 王跃建 Il-10多肽抑制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
EP0365525B1 (en) 1987-01-30 1995-08-09 The Board Of Trustees Of The Leland Stanford Junior University Lymphocyte inhibition by hla peptides
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US5385888A (en) * 1987-03-20 1995-01-31 The Regents Of The University Of California Class I MHC modulation or surface receptor activity
JP3015058B2 (ja) 1989-03-03 2000-02-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 表面レセプター活性のクラスｉｍｈｃ調節
NZ270605A (en) * 1991-08-26 1997-07-27 Cytel Corp Cytotoxic t lymphocyte inducing peptides (6-19 amino acids) and pharmaceutical compositions thereof
EP0661985B1 (en) 1991-11-08 1999-07-07 The Board Of Trustees Of The Leland Stanford Junior University Peptides capable of binding cd8 molecules on ctl precursors
US5440015A (en) 1992-07-21 1995-08-08 Glycomed Incorporated Selectin peptide medicaments for treating disease
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
CA2176208A1 (en) * 1993-11-10 1995-05-18 Carol Clayberger Surface membrane proteins and their effect on immune response
CA2181787A1 (en) * 1994-03-03 1995-09-08 Claire M. Doerschuk Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
CA2210812C (en) * 1995-01-16 2009-09-01 Nicholas Manolios T-cell affecting peptides
US6162434A (en) * 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US5753625A (en) * 1995-05-12 1998-05-19 Sangstat Medical Corporation Treatment for inhibiting the progression of autoimmune disease
WO1997024140A1 (en) 1996-01-02 1997-07-10 The Board Of Trustees Of Leland Stanford Junior University Interaction of hla proteins with members of the hsp70 family of proteins
US6436903B1 (en) 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
WO1997044351A1 (en) 1996-05-24 1997-11-27 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US6696545B1 (en) * 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation

Similar Documents

Publication Publication Date Title
JP2000509637A5 (ja)
JP2000507042A5 (ja)
JP2000509635A5 (ja)
JP2001519070A5 (ja)
JP2002503166A5 (ja)
JP2000507433A5 (ja)
JP2000509587A5 (ja)
JP2000507369A5 (ja)
JP2001509679A5 (ja)
JP2001509029A5 (ja)
JP2001507750A5 (ja)
JP2002513531A5 (ja)
JP2001525044A5 (ja)
JP2000510793A5 (ja)
JP2000508866A5 (ja)
JP2000508022A5 (ja)
JP2000508841A5 (ja)
JP2000508680A5 (ja)
JP2000509755A5 (ja)
JP2000510969A5 (ja)
JP2000508836A5 (ja)
JP2000510247A5 (ja)
JP2000509520A5 (ja)
JP2000508880A5 (ja)
JP2000509754A5 (ja)